Platinum-Resistant Ovarian CarcinomaPhase 1NCT05225363Papers
Chimeric Antigen Receptor T-cells
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer
48 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Ovary and gynecologic48 studies
Platinum-Resistant Ovarian CarcinomaPhase 1NCT05225363Papers
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer
Ovarian Clear Cell AdenocarcinomaФаза 2NCT05231122
Anti-CD40 Agonist Monoclonal Antibody CDX-1140, Bevacizumab, Pembrolizumab, Quality-of-Life Assessment
Platinum-Sensitive Recurrent Ovarian and Endometrial CancerPhase 1/2NCT06040970
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
Stage IVB Cervical CancerPhase 1/2NCT06543576
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
Recurrent or Unresectable pMMR Endometrial (Uterine) CancerPhase 1NCT05603910
Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma
Uterine Cervix CancerФаза 2NCT06331468
Cisplatin, intensity modulated radiation therapy (IMRT), high-dose-rate (HDR) brachytherapy
Uterine LeiomyosarcomaФаза 2NCT05649956
Letrozole
Cervical CancerФаза 2NCT05838521
Sacituzumab govitecan
Cervical Intraepithelial Neoplasia and Invasive Cervical CancerPhase 1NCT06191133
Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
Ovarian CancerФаза 2NCT04918186Papers
Durvalumab, BA3011, BA3021, ENB003
Recurrent Endometrial CarcinomaФаза 2NCT04469764
Abemaciclib, Anastrozole, Letrozole
Ovarian CancerФаза 2NCT06906341
Relacorilant 150 mg once daily (QD), Nab-paclitaxel 80 mg/m^2, Bevacizumab 10 mg/kg
Ovarian CancerФаза 2NCT04606914
mirvetuximab soravtansine (MIRV; IMGN853)
Ovary CancerФаза 2NCT05887609
Mirvetuximab Soravtansine-gynx, Olaparib
Platinum-resistant Ovarian CancerФаза 2NCT06710288
Gemcitabine, N-803, M-CENK
Ovarian CancerФаза 2NCT05952453
Carboplatin, olaparibp, embro
Endometrial CancerФаза 2NCT03832361
IMGN853
Ovarian NeoplasmsФаза 2NCT04641247
Niraparib
HER2/Neu+ Uterine Serous CarcinomaФаза 2NCT02491099Papers
Afatinib
Platinum-Resistant Fallopian Tube CarcinomaФаза 2NCT05538091
Vismodegib, Atezolizumab
Ovarian CancerФаза 2NCT05071937
ZEN003694, Talazoparib
Platinum-resistant Ovarian CancerPhase 1NCT06321484
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
Cervical CancersФаза 2NCT07022470
3-Fraction HDR Brachytherapy, 4-Fraction HDR Brachytherapy
Recurrent Ovarian CancerPhase 1/2NCT05610735
Combination Therapy for Recurrent Ovarian Cancer